Key Insights

Highlights

Treatment Research

2 treatments under study, led by Excimer Laser

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 80/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed with results

Key Signals

1 with results0

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Terminated1

Clinical Trials (1)

Showing 1 of 1 trials
NCT02181790Phase 4TerminatedPrimary

Addition of Excimer Laser to Treatment With Acitretin Tablets for Psoriasis of the Palms and Soles

Showing all 1 trials

Research Network

Common Treatments

  • Excimer Laser1
  • Acitretin1

Active Sponsors

  • Icahn School of Medicine at Mount Sinai1

Top Investigators

Activity Timeline